Targeted treatments for hidradenitis suppurativa: a review of the current literature and ongoing clinical trials
Purpose: Targeted, immune-modulating drugs are at the forefront of therapy for HS, and a comprehensive clinical trial registry is needed to facilitate data pooling and clinical efficacy comparison. Materials and methods: A systematic review of the ClinicalTrials.gov database was searched for planned...
Main Authors: | Melody Maarouf, Ashley K. Clark, Dylan E. Lee, Vivian Y. Shi |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-07-01
|
Series: | Journal of Dermatological Treatment |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09546634.2017.1395806 |
Similar Items
-
Hidradenitis suppurativa - current and promising non-surgical treatment
by: Natalia Baran, et al.
Published: (2023-07-01) -
Efficacy of adalimumab in moderate to severe hidradenitis suppurativa: Real life data
by: Aikaterini Kyriakou, et al.
Published: (2018-10-01) -
Epidemiology of hidradenitis suppurativa in Poland in relation to international data
by: Łukasz Matusiak, et al.
Published: (2017-09-01) -
Correlation of Increased Total Serum Immunoglobulin E Levels and Hidradenitis Suppurativa
by: Ballova A, et al.
Published: (2021-03-01) -
Immunomodulatory Drugs in the Treatment of Hidradenitis Suppurativa—Possibilities and Limitations
by: Zuzanna Świerczewska, et al.
Published: (2022-08-01)